Overall, MMP dysregulation in systemic sclerosis reflects a complex imbalance between decreased MMP-1 and MMP-13 (profibrotic suppression) and increased MMP-9, MMP-14, and MMP-7 (proinflammatory activation). This evidence concerns the gene MMP9 and systemic sclerosis.